Azioni LexaGene Holdings Inc. Toronto S.E.
Azioni
LXG.H
CA52886L1031
Biotecnologia
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Variaz. 1 gen. | Capi. | |
---|---|---|
-27,01% | 10,26 Mrd | |
+31,86% | 3,04 Mrd | |
-8,58% | 2,94 Mrd | |
-13,62% | 2,19 Mrd | |
-16,32% | 1,72 Mrd | |
+63,36% | 1,4 Mrd | |
+27,00% | 780 Mln | |
-2,18% | 736 Mln | |
-19,18% | 560 Mln |